Healthcare companies have been feverishly working on developing GLP-1 weight loss products in an effort to cash in on what's turning out to be a massive gold rush in the sector. Companies big and small have GLP-1 drug candidates in development that, if successful, could be game changers for their businesses. It could put small stocks on the map, and for larger companies, it could mean an improvement in their growth rates. It may seem exciting to invest in GLP-1 stocks for their future growth potential, b ...